Background: Rehabilitation robots can provide exercise for stroke survivors with
Introduction
Stroke is the commonest cause of acquired severe disability in adults of working age in developed countries. Approximately 150,000 people have a stroke each year in the UK and up to 85% of these people experience upper limb paresis at onset. [1] The amount of exercise therapy that people receive determines the speed and completeness of recovery in the arm. [2] However, conventional physical and occupational therapy is resource-limited. This is important because arm function contributes to personal independence and self-esteem. Independence in many activities of daily living requires efficient smooth reach-to-grasp movement. Temporal and spatial coordination between shoulder, elbow, wrist and finger movements are key to this process. In normal human movement there is relative invariance in the temporal coordination of reaching and hand opening, indicating that for most reach to grasp movements that the timing of hand opening is coordinated with the phase of the reaching movement to the target.
Sensory and motor impairments can cause loss of coordination between reaching and hand opening. This results in a reduction in accuracy and efficiency of reach to grasp movements. Although there are many factors contributing to this, for the purposes on this investigation we are focused on the motor impairments that affect the spatial and temporal aspects of efficient reach to grasp.
We have developed a novel robotic system, iPAM (intelligent Pneumatic Arm Movement), to assist patients in undertaking additional therapeutic exercise with minimal input from the therapist. [3] It assists the person to undertake active reaching iPAM-NMES Resubmission 27 05 2015 4 exercises and addresses weakness of shoulder, upper arm, and elbow and forearm movements. It supplements, but does not replace, therapists' input. However, one of the limitations of robotic devices in providing rehabilitation is the lack of assisted hand opening for those patients where not only reaching ability is impaired but also the ability to smoothly open the hand during a reach to grasp arm movement.
Neuromuscular electrical stimulation (NMES) can provide a relatively simple way to provide assisted hand opening by electrically stimulating certain muscles of the forearm which are concerned with wrist and finger extension movement. NMES devices are commonly used in healthcare settings to address muscle weakness in conditions such as stroke.
The aim of this study is to investigate the feasibility of using iPAM with NMES within a laboratory setting to provide simultaneous hand opening exercises during assisted reaching exercises for stroke survivors who have moderate to severe arm weakness.
The rationale for investigating a combined approach is that it more realistically mimics normal prehension rather than developing an intervention that involves undertaking NMES hand opening exercises separately from reaching exercises. This is in keeping with device development and concurs with the MRC guidance on the evaluation of complex health care interventions in the context of phase 1 clinical trials. While it is usually unacceptable to modify an intervention during the course of an RCT, an exploratory or feasibility trial can be developed to explicitly explore the nature of the intervention and build up safety data prior to a formal controlled clinical trial. Therefore the objectives of this feasibility study were: (a) to determine whether the robot and NMES combined therapy can provide the type of movement therapy iPAM-NMES Resubmission 27 05 2015 5 that is deemed necessary by the physiotherapist; (b) to assess patient compliance/comfort, and usefulness to physiotherapists in terms of its flexibility in providing different arm/hand exercises; (c) to inform a future larger randomised clinical trial of the intervention dose, appropriate outcomes and practicality of using the equipment. 
Methods

The iPAM Mk2 system
iPAM Mk2 is a dual robot system designed to mimic the manner in which a physiotherapist facilitates assisted upper-limb exercise [ Figure 1 ]. Two identical robot arms, each consisting of three pneumatically powered revolute joints, attach to the patient's upper-limb via two custom designed orthoses. [4] A distal orthosis attaches to the forearm close to the wrist while a proximal orthosis attaches at the mid-point of the upper-arm. The ends of each robot can be exchanged to provide both left and right-sided operation. Each orthosis allows three passive rotational degrees of freedom (DoF) aligned through the centre of the limb, preventing unwanted torques being applied at the attachment points. Rotary sensors measure the rotation of the six active robot joints while two six-DoF force/torque transducers record the relative forces between the robot and the patient's limb. Depending on the category of exercise, iPAM will automatically adjust parameters, such as increasing the movement range or reducing the assistance provided by the system, as the patient progresses.
Neuromuscular Electrical Stimulation System
The NMES system used in this study is a commercially available Odstock PACE Electrodes were placed over the extensor aspect of the forearm on the side affected by the stroke. The active electrode was placed over the motor points of extensor carpi radialis brevis and longus and extensor digitorum communis muscles. The indifferent 9 electrode was placed over the motor points of extensor pollicis longus and abductor pollicis longus.
Equipment Interface
In order to allow the Odstock PACE stimulator to be triggered by iPAM changes to the system hardware of iPAM Mk2 were required. An existing digital output from the chassis was used to trigger the NMES. The 3.4v signal from the digital line is used to turn on a solid-state relay (SSR). The output line of the SSR was then connected to a 2.5mm audio jack socket on the iPAM base unit. A connection lead was made to connect the external trigger input of the NMES stimulator to the iPAM base unit.
When the digital line is set to high, it allows current to flow through the external trigger circuit. When the digital line is then set to low, the SSR turns off and the external trigger appears off. The Odstock PACE is set to operate on the falling edge of the external trigger. An image of the Odstock PACE connected to iPAM is shown in Figure 2 .
Figure 2 about here
In order to incorporate the triggering of the NMES within the iPAM system, it was necessary to make several changes to the low-level control software. So that the NMES triggers appropriately during each exercise, i.e. the patient's hand will open realistically in a reach-and-grasp movement, a strategy was developed to trigger the NMES at a particular point during the active exercises. For each exercise, the 10 system determines a component, which is the movement from one virtual target to the next. During the arm movement, one would expect the hand to open at a particular point in that component. The point at which hand opening would be initiated in a reach-and-grasp movement is the active radius. The active radius percentage is the percentage of the distance between starting a movement and when the hand would begin to open, and the overall distance between the start point and the final target. For the purposes of this treatment, as the hand opening is triggered by NMES, we have termed the point at which NMES should trigger hand opening as the NMES active radius. The system determines, for each component, the straight-line distance between the previous (or start hand position in the case of the first component) and the current target and then calculates an NMES active radius based on this distance and the NMES radius percentage value as these will vary depending on the overall distance the patient's hand travels. If needed, the NMES radius percentage parameter can be altered by the physiotherapist using the clinician interface.
During exercises, iPAM monitors the distance between the patient's hand and the current target. When the patient gets within the NMES active radius of the target, the NMES triggers by setting the digital line for the NMES to high and then low again. As the purpose of iPAM therapy is to enhance upper limb movement, therapies concentrated on overall movements of the upper limb. Due to the velocity at which these exercises were intended to be performed, it was not possible to trigger the NMES on every component, as we found the extensor muscles of the forearm were refractory to stimulation when stimulated too quickly in succession. Instead, the 11 NMES was set to trigger on only odd numbered components. Changes were made to the patient interface to include an indicator to show when the hand should open during the movement. The patient interface during active exercises is shown in figure   3 . give informed consent, or any medical issues which would affect their safe participation with the combined therapy. The plan of the phase 1 study was to recruit up to 10 patients and undertake up to 10 treatment sessions each. While improvements in patient movement and function would be considered a successful outcome of the trial, the main aim was to determine the potential of iPAM -NMES as a combined therapy with up to10 patients.
Research intervention
These exploratory trials took place at The Charterhouse Rehabilitation Technologies Laboratory, a purpose-built laboratory for rehabilitation technology research, at the 12 University of Leeds. It is situated on the ground floor allowing convenient access.
The laboratory was partitioned as required for each session to allow separate areas for clinical assessment, iPAM exercise and break periods. All sessions were run by the iPAM research physiotherapist.
In order to ensure that the participant's impairment was amenable to NMES, written, informed Stage 1 Consent was obtained. Participants were then clinically assessed and NMES was applied to the forearm to stimulate hand opening and settings adjusted as required to obtain comfortable, adequate hand opening with the arm at rest while seated at a table and when performing reaching movements with facilitation by the research physiotherapist. If the research physiotherapist considered that the NMES effectively opened the participants' hand, and the participant wished to continue, he or she was then invited to sign Stage 2 of the written informed consent and proceed to completing the full set of outcome assessments and agree a rehabilitation prescription. complete. The participants' arm movements will be captured on digital camera during ARAT tasks for review of the qualitative aspects of arm and hand movement during reaching and grasping tasks. The test is scored out of 57.
Outcome assessments
3. Stroke Impact Scale (SIS) is a stroke specific questionnaire that measures the impact of stroke on participants, and it has been widely used as the outcome measure in randomised controlled trails and more specifically in robot rehabilitation studies. [7] It is a reliable and valid scale for assessing overall outcome of people with stroke. This questionnaire takes approximately 15-20 minutes to complete. It is scored out of 295, but is transformed to a 0 -100 scale.
Outcome measures were completed with support from the research therapist as required to assist participants with communication or writing impairments. A single set of outcomes was recorded during visits to the research laboratory before commencing any experimental treatment and a further set was recorded on conclusion of the intervention. On conclusion of their involvement in the study, participants also completed a user satisfaction questionnaire adapted from instruments used in previous user-centred design projects in our Department.
Participants were encouraged to provide free comments and suggestions for improvement.
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iPAM -NMES treatment sessions
At each session, a brief clinical assessment was done to ensure it was appropriate to conduct the session and to guide the appropriate rehabilitation prescription. At the first session the required measurements were done for iPAM set-up. Participants completed up to 60 repetitions over 45 minutes at each session. At all sessions NMES was set up and appropriate muscle contraction obtained away from iPAM and then the usual iPAM set-up procedure was followed with a set of standardized iPAM exercises with NMES in situ but turned off. NMES was then manually triggered by the research physiotherapist for a few initial exercises followed by NMES set to automatically trigger as required for optimum hand opening and participant comfort. 
Results
Recruitment
Twenty potential participants were provided with information in the study by staff from the NHS stroke rehabilitation teams in Leeds, of whom 13 made contact with the study physiotherapist. Ten participants met the inclusion criteria to take part in this exploratory study. Following recruitment, one participant no longer wished to participate and withdrew from the study. The demographics of the remaining nine participants are outlined in Table 1 .
Table 1 about here
Two participants (NMES 07 and NMES 08) received no iPAM-NMES treatment due to recurrent malfunctions with the technology which were not resolved until after the treatment period of the study had completed. The other participants received between one and ten sessions of treatment before the treatment period of the study finished.
Outcome measures
The two participants who did not receive any treatments did not complete the follow up standard clinical outcome measures or the iPAM patient feedback questionnaire. 
SIS Scores
The mean Stroke Recovery Score at baseline was 49 which improved to 60 at follow-up (p = 0.019). 
Adverse events
There was one serious adverse event and one adverse event. Thirteen days after receiving two treatment sessions, a participant fell at home sustaining a fractured hip. Following surgery and a recovery period, he resumed his participation in the trial eight weeks after the fall and completed the study treatment. It was not felt that this event was directly related to the study. Another participant noted during his first treatment session that his arm felt tight having completed 63 repetitions of the exercise programme. This resolved and did not recur during subsequent sessions. during the use of any rehabilitation technology. A therapeutic decision has to be made during the delivery of combination therapy whether to prioritise the exercise for the session as hand opening or a reaching movement from the shoulder and elbow as the settings required for each may conflict. This decision has to be taken to balance the optimal therapeutic movement and the disruption to therapy and therapist time needed to make these adjustments. This study is limited by the small number of participants and the relatively small quantity of treatment each participant received. In addition, there was substantial variability amongst the participants in terms of since stroke, severity of impairments and the amount of treatment received. Therefore, it was not possible to perform any subgroup analyses to suggest whether the treatment was any more beneficial in the first year after stroke compared to the second and subsequent years nor whether there was the response related to the amount of treatment.
Furthermore, as we only collected one set of baseline measures before treatment commenced, it was not possible to determine if participants' disabilities were changing due to natural recovery. While the improvements in patient movement and function were gratifying outcomes, the main aim of the trial was to determine the potential of iPAM -NMES as a combined therapy and so the trial was not powered to detect a difference greater than would be noted due to natural recovery following stroke. The generally accepted definition of chronic stroke is persistence of disability six months after stroke [8] and although the amount of improvement more than six months after stroke would necessarily be limited, there is a possibility that the 20 changes seen were due to natural recovery. An alternative view is that there is potential for further recovery and iPAM -NMES is a useful strategy to unlock this potential.
These points need to be considered when implementing this treatment into routine clinical rehabilitation. There is no reason to believe that the treatment would not work for other central nervous conditions that cause upper limb impairment such as hemiplegic traumatic brain injury or tetraplegic spinal cord injury. Widening the indications for this treatment will improve cost effectiveness for centres purchasing the device. Extra time from a qualified therapist will be required for patients who are commencing this treatment, but once set up patients will continue to exercise independently for the remaining time. This frees the skilled therapist to do more sophisticated tasks for patients requiring individualised assessments or treatments.
The literature on arm recovery after stroke, indeed recovery of any activity after any neurological injury, strongly suggests that recovery of function is directly related to the amount of practise. [2] Despite the low number of treatments received by participants in this study, small, but important, improvements were noted in their level of functioning, indicating that further recovery may be possible for stroke survivors months, and sometimes years, after a stroke. This may be because participants in this study actively assisted in their exercises, which is known to promote recovery, probably through physiological muscle activation and afferent proprioceptive input enhancing the training effect of the exercise. [9, 10] 21
Conclusion
The objectives of this study were to determine if a combination therapy of robotic and electrical stimulation was feasible and acceptable to patients and therapists. These objectives were met and this is the first study to report that a combination of robotic upper limb therapy with functional electrical stimulation can be used in a group of chronic stroke survivors with persisting upper limb impairments. Based on the findings in this report, future work is planned to explore the possibilities of further combinations, including in lower limb rehabilitation, and to optimise the characteristics of robotic and stimulation parameters. I was intimidated using the robot 2 5
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The robot was easy to attach to my upper arm.
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